Conduct fast, efficient, and representative trials. Accelerate patient recruitment, increase trial diversity, leverage external control arms — and more
See patient journeys in granular detail. Understand the journey to diagnosis and treatment pathways, then model custom patient cohorts to assess the impact of study criteria and protocol design.
Surface Principal Investigators (PI) who are treating screening-eligible patients in both academic and community settings. Select trial sites by defining disease burden at the ZIP-3 level.
Use patient-level race and ethnicity insights for 265 million individuals — aligned to the population at the state level. Model inclusion/exclusion criteria to optimize PI and site selection.
Find out how we can help you overcome your biggest healthcare challenges.
Use clinical alerts to reach HCPs before treatment decisions are made. Configure alerts with auto-mapping to find patients near existing trial sites.
Link trial data to real-world data sources to maximize insights and efficiencies. Gain an understanding of patient outliers, create external control arms, conduct subpopulation analyses, and monitor long-term outcomes.
Link specialty data sources such as lab, clinical, EHR, oncology, genomics, and race and ethnicity to our comprehensive Healthcare Map for a certified, fit-for-purpose dataset to start immediate analysis.

Pierre Sayad, PhD
VP, Global Medical and Scientific Affairs, Karyopharm Therapeutics